The Infona portal uses cookies, i.e. strings of text saved by a browser on the user's device. The portal can access those files and use them to remember the user's data, such as their chosen settings (screen view, interface language, etc.), or their login data. By using the Infona portal the user accepts automatic saving and using this information for portal operation purposes. More information on the subject can be found in the Privacy Policy and Terms of Service. By closing this window the user confirms that they have read the information on cookie usage, and they accept the privacy policy and the way cookies are used by the portal. You can change the cookie settings in your browser.
Background
Mutations of AT‐rich interactive domain 1 (ARID1A) have been associated with a worse outcome after intravesical treatment with bacille Calmette‐Guérin in patients with non–muscle‐invasive bladder cancer (NMIBC). Loss of ARID1A protein expression in urine cytology may serve as an indication of an ARID1A mutation. Therefore, the authors examined the expression of ARID1A in urine cytology...
AimsTo construct a prognostic model, incorporating clinicopathological variables and biomarkers, to predict recurrence, progression and cancer‐specific mortality for patients who have undergone transurethral resection of non‐muscle‐invasive bladder cancer (NMIBC).
Methods and resultsA total of 12 biomarkers were evaluated using immunohistochemical analysis of tissue arrays of 605 NMIBCs. Competing...
Set the date range to filter the displayed results. You can set a starting date, ending date or both. You can enter the dates manually or choose them from the calendar.